These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15152458)

  • 1. [Cardiopulmonary failure in Duchenne muscular dystrophy--pathophysiology and management].
    Ishihara T
    Rinsho Shinkeigaku; 2003 Nov; 43(11):761-4. PubMed ID: 15152458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Management of patients with Duchenne muscular dystrophy].
    Ishihara T
    No To Hattatsu; 2004 Mar; 36(2):130-5. PubMed ID: 15031987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of myocardial damage in muscular dystrophy].
    Tamura T
    Brain Nerve; 2011 Nov; 63(11):1217-28. PubMed ID: 22068474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of intermittent positive pressure ventilation on life-span and causes of death in Duchenne muscular dystrophy].
    Konagaya M; Sakai M; Wakayama T; Kimura S; Kuru S; Yasuma F
    Rinsho Shinkeigaku; 2005 Sep; 45(9):643-6. PubMed ID: 16248395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure.
    Law YM; Ettedgui J; Beerman L; Maisel A; Tofovic S
    Am J Cardiol; 2006 Aug; 98(4):520-4. PubMed ID: 16893709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effective milrinone therapy to a Duchenne muscular dystrophy patient with advanced congestive heart failure].
    Matsumura T; Saito T; Miyai I; Nozaki S; Kang J
    Rinsho Shinkeigaku; 1999 Jun; 39(6):643-8. PubMed ID: 10502990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of end stage respiratory failure in Duchenne muscular dystrophy.
    Bach JR; O'Brien J; Krotenberg R; Alba AS
    Muscle Nerve; 1987 Feb; 10(2):177-82. PubMed ID: 3547120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep-related breathing disorder in Duchenne muscular dystrophy: disease spectrum in the paediatric population.
    Suresh S; Wales P; Dakin C; Harris MA; Cooper DG
    J Paediatr Child Health; 2005; 41(9-10):500-3. PubMed ID: 16150067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [BNP measurement for perioperative management].
    Ishiguro T; Gyouda Y; Yoshizawa A; Arakawa K
    Masui; 2009 May; 58(5):604-8. PubMed ID: 19462798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy.
    Jefferies JL; Eidem BW; Belmont JW; Craigen WJ; Ware SM; Fernbach SD; Neish SR; Smith EO; Towbin JA
    Circulation; 2005 Nov; 112(18):2799-804. PubMed ID: 16246949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure.
    Iwanaga Y; Nishi I; Furuichi S; Noguchi T; Sase K; Kihara Y; Goto Y; Nonogi H
    J Am Coll Cardiol; 2006 Feb; 47(4):742-8. PubMed ID: 16487838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders.
    Bourke JP
    Dev Med Child Neurol; 2006 Mar; 48(3):164. PubMed ID: 16483389
    [No Abstract]   [Full Text] [Related]  

  • 13. [Respiratory failure and its care in Duchenne muscular dystrophy].
    Fukunaga H; Sonoda Y; Atsuchi H; Osame M
    Rinsho Shinkeigaku; 1991 Feb; 31(2):154-8. PubMed ID: 2060238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of deflazacort on cardiac and sternocleidomastoid muscles in Duchenne muscular dystrophy: a magnetic resonance imaging study.
    Mavrogeni S; Papavasiliou A; Douskou M; Kolovou G; Papadopoulou E; Cokkinos DV
    Eur J Paediatr Neurol; 2009 Jan; 13(1):34-40. PubMed ID: 18406648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of non-invasive ventilation on respiratory muscle loading and endurance in patients with Duchenne muscular dystrophy.
    Toussaint M; Soudon P; Kinnear W
    Thorax; 2008 May; 63(5):430-4. PubMed ID: 18057095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload.
    Holmgren D; Westerlind A; Lundberg PA; Wåhlander H
    Clin Physiol Funct Imaging; 2005 Sep; 25(5):263-9. PubMed ID: 16117728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of growth hormone treatment on B-type natriuretic peptide as a marker of heart failure in adults with growth hormone deficiency.
    Wallaschofski H; Saller B; Spilcke-Liss E; Lerch MM; Lohmann T; Eigenthaler M
    Horm Metab Res; 2006 Oct; 38(10):656-61. PubMed ID: 17075774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac involvement in Beagle-based canine X-linked muscular dystrophy in Japan (CXMDJ): electrocardiographic, echocardiographic, and morphologic studies.
    Yugeta N; Urasawa N; Fujii Y; Yoshimura M; Yuasa K; Wada MR; Nakura M; Shimatsu Y; Tomohiro M; Takahashi A; Machida N; Wakao Y; Nakamura A; Takeda S
    BMC Cardiovasc Disord; 2006 Dec; 6():47. PubMed ID: 17140458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current approaches to monitoring and management of heart failure.
    Yancy CW
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S25-32. PubMed ID: 16955057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
    Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
    J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.